Literature DB >> 19756425

Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy.

Chiao-Ling Tsai1, Jian-Kuen Wu, Chun-Wei Wang, Feng-Ming Hsu, Ming-Kuen Lai, Jason Chia-Hsien Cheng.   

Abstract

PURPOSE: To assess bladder filling status and its impact on target position during daily intensity-modulated radiation therapy (IMRT) using cone-beam computed tomography (CBCT) in prostate cancer patients. PATIENTS AND METHODS: 23 patients with prostate cancer undergoing image-guided IMRT (78 Gy in 39 fractions) were included. On-board CBCT images were acquired daily and an endorectal balloon was placed daily. All patients were instructed to have a full bladder. The interfraction changes in bladder dimensions in left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions were measured from CBCT images. Distances from the uppermost part of prostate to pubic bone (PP) and from the uppermost part of prostate to treatment isocenter (PI) were measured to determine changes in target position. Standard deviation (SD) in all fractions of each patient was used to compare the variations between patients. Bladder dimension change ratio and Z-score were used to normalize data between patients.
RESULTS: A total of 867 CBCT images were evaluated. The average LR, AP, and SI bladder dimensions were 7.8 +/- 1.5 cm, 6.7 +/- 1.4 cm, and 5.6 +/- 1.7 cm, respectively. The average LR, AP, and SI bladder dimension change ratios were 0.88 +/- 0.17, 0.90 +/- 0.15, and 0.86 +/- 0.32, respectively. The SD was significantly greater in SI dimension than in LR (p < 0.001) and AP (p < 0.001) dimensions. The interfraction changes in the three bladder dimensions were significantly larger than those of target position, and did not correlate with target position changes.
CONCLUSION: Though they were not negligible, changes in bladder filling status did not have a significant impact on target position.

Entities:  

Mesh:

Year:  2009        PMID: 19756425     DOI: 10.1007/s00066-009-1987-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  20 in total

1.  A practical method to achieve prostate gland immobilization and target verification for daily treatment.

Authors:  A V D'Amico; J Manola; M Loffredo; L Lopes; K Nissen; D A O'Farrell; L Gordon; C M Tempany; R A Cormack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

2.  Comparative analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients.

Authors:  Tae Hyun Kim; Dae Yong Kim; Kwan Ho Cho; Young Hoon Kim; Kyung Hae Jung; Joong-Bae Ahn; Hee Jin Chang; Joo-Young Kim; Hyo Seong Choi; Seok-Byung Lim; Dae Kyung Sohn; Seung-Yong Jeong
Journal:  Strahlenther Onkol       Date:  2005-09       Impact factor: 3.621

3.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI).

Authors:  Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

4.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers.

Authors:  J M Balter; H M Sandler; K Lam; R L Bree; A S Lichter; R K ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-01       Impact factor: 7.038

5.  Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer.

Authors:  Barbara Alicja Jereczek-Fossa; Federica Cattani; Cristina Garibaldi; Dario Zerini; Raffaella Cambria; Genoveva Ionela Boboc; Marco Valenti; Anna Kowalczyk; Andrea Vavassori; Giovanni Battista Ivaldi; Mario Ciocca; Deliu Victor Matei; Ottavio De Cobelli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

6.  Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.

Authors:  Hassan Elsayed; Tobias Bölling; Christos Moustakis; Stefan-Bodo Müller; Patrick Schüller; Iris Ernst; Normann Willich; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

7.  Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.

Authors:  Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

8.  Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice.

Authors:  Matthias Guckenberger; Juergen Meyer; Juergen Wilbert; Kurt Baier; Otto Sauer; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2007-06       Impact factor: 3.621

9.  Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.

Authors:  Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jörn Kalz; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

10.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.

Authors:  J C Roeske; J D Forman; C F Mesina; T He; C A Pelizzari; E Fontenla; S Vijayakumar; G T Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-12-01       Impact factor: 7.038

View more
  20 in total

1.  Phase-specific cone beam computed tomography reduces reconstructed volume loss of moving phantom.

Authors:  H-L Chao; W-L Chen; C-C Hu; J-K Wu; C-J Wu; J C-H Cheng
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

Review 2.  kV cone-beam CT-based IGRT: a clinical review.

Authors:  Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

Review 3.  Motion correction options in PET/MRI.

Authors:  Ciprian Catana
Journal:  Semin Nucl Med       Date:  2015-05       Impact factor: 4.446

4.  Practically acquired and modified cone-beam computed tomography images for accurate dose calculation in head and neck cancer.

Authors:  Chih-Chung Hu; Wen-Tao Huang; Chiao-Ling Tsai; Jian-Kuen Wu; Hsiao-Ling Chao; Guo-Ming Huang; Chun-Wei Wang; Chien-Jang Wu; Jason Chia-Hsien Cheng
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

5.  Three-dimensional patient setup errors at different treatment sites measured by the Tomotherapy megavoltage CT.

Authors:  S K Hui; E Lusczek; T DeFor; K Dusenbery; S Levitt
Journal:  Strahlenther Onkol       Date:  2012-03-09       Impact factor: 3.621

6.  Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Dario Zerini; Federica Cattani; Flavia Serafini; Rosa Luraschi; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

7.  Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia: treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractions.

Authors:  Kiyoshi Nakamatsu; Yasumasa Nishimura; Shuichi Kanamori; Ryuta Koike; Izumi Tachibana; Tatsuyuki Nishikawa; Toru Shibata
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

8.  Daily patient setup error in prostate image guided radiation therapy with fiducial-based kilovoltage onboard imaging and conebeam computed tomography.

Authors:  Jason C Ye; Muhammad M Qureshi; Pauline Clancy; Lauren N Dise; John Willins; Ariel E Hirsch
Journal:  Quant Imaging Med Surg       Date:  2015-10

9.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

Review 10.  Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Mol Life Sci       Date:  2016-03-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.